A Study Based on Data From German Registries That Looks at Characteristics of People Who Take the Medicine Empagliflozin for Type 2 Diabetes
Clinical trial NCT04098575 · COMPLETED
Trial details
- NCT number
- NCT04098575
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-16
- Primary completion
- 2019-12-31
- Enrollment
- 9571
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.